Jump to main content

yr 〜
yr

Search results 4

Association between soluble immune mediators and tumor responses in patients with non-small cell lung cancer treated with anti-PD-1 inhibitor

Association between soluble immune mediators and tumor responses in patients with non-small cell lung cancer treated with anti-PD-1 inhibitor
Digital博士論文障害者向け資料あり
松尾, 規和2019-01-31
National Diet Library
  • Subject HeadingCXCL2 MMP2 PD-1 PD-L1 adverse events nivolumab pembrolizumab

Efficacy of pembrolizumab in patients with brain metastasis caused by previously untreated non-small cell lung cancer with high tumor PD-L1 expression

Efficacy of pembrolizumab in patients with brain metastasis caused by previously untreated non-small cell lung cancer with high tumor PD-L1 expression
Digital博士論文障害者向け資料あり
和久田,一茂2024-03-25
Available onlineNational Diet LibraryOther Libraries in Japan
  • Subject Heading...ain metastasis Pembrolizumab non-small cell lung cancer hi...
  • Alternative TitlePD-L1 高発現、未治療非小細胞肺癌の脳転移に対するPembrolizumabの有効性の検討
  • Alternative TitlePD-L1 高発現、未治療非小細胞肺癌の脳転移に対するPembrolizumabの有効性の検討

進行非小細胞肺癌に対するPembrolizumabの使用経験

進行非小細胞肺癌に対するPembrolizumabの使用経験
Digital文書・図像類
福田, 正明, 中尾, 匠, 原田, 陽介, 北崎, 健, 橋口, 浩二日本赤十字社医学会2018-09-01日赤医学70 1p.223-223
Other Libraries in Japan
  • Subject Heading非小細胞肺癌 Pembrolizumab 抗PD-1抗体

Association between soluble immune mediators and tumor responses in patients with non-small cell lung cancer treated with anti-PD-1 inhibitor

Association between soluble immune mediators and tumor responses in patients with non-small cell lung cancer treated with anti-PD-1 inhibitor
Digital博士論文
松尾, 規和
Available onlineOther Libraries in Japan
  • Subject HeadingCXCL2 MMP2 PD-1 PD-L1 adverse events nivolumab pembrolizumab

Reached to the end of result.

RSS